Effect of two cyclosporin regimens on cancer frequency in kidney-graft recipients.
Birkeland
S A
SA
D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D016030:Kidney Transplantation; D008297:Male; D009369:Neoplasms / Q000209:etiology*
D007166:Immunosuppressive Agents; D016572:Cyclosporine